MM

Michael S. Oldham, MD, MPH

Vice President, Clinical Development at Entrada Therapeutics

Michael S. Oldham, MD, MPH has a diverse work experience spanning across multiple companies and roles. Michael S. is currently serving as the Executive Medical Director at Entrada Therapeutics since July 2022. Prior to this, they held the position of Executive Medical Director at Praxis Precision Medicines, Inc. from January 2022 to June 2022, and Senior Medical Director from December 2020 to January 2022.

Before joining Praxis Precision Medicines, Inc., Dr. Oldham worked as a Medical Director at Medpace from November 2017 to December 2020. Michael S. also served as a Senior Medical Director at US WorldMeds from December 2016 to November 2017.

Dr. Oldham's earlier experience includes being an Assistant Professor in the Department of Neurology, Division of Child Neurology at the University of Louisville School of Medicine from October 2015 to December 2016. Michael S. also completed a Clinical Neurophysiology Fellowship at the University of California, San Francisco from 2014 to 2015.

Michael S.'seducational background includes a Pediatrics/Child Neurology Combined Residency at Cincinnati Children's Hospital Medical Center from 2009 to 2014. Dr. Oldham holds an MD and an MPH degree as well.

Michael S. Oldham, MD, MPH obtained their Bachelor of Arts (BA) degree in Psychology from Georgetown University in 2001. Michael S. then pursued a Master of Public Health (MPH) degree from the Johns Hopkins Bloomberg School of Public Health, completing it in 2007. Subsequently, they attended The George Washington University School of Medicine and Health Sciences, where they obtained their Doctor of Medicine (MD) degree in 2009. Additionally, they have certifications in Epilepsy and Neurology with Special Qualification in Child Neurology from the American Board of Psychiatry and Neurology, Inc. The specific dates of obtaining these certifications are not provided.

Links

Previous companies

Medpace logo

Org chart

Peers

Timeline

  • Vice President, Clinical Development

    January 1, 2024 - present

  • Executive Medical Director

    July, 2022

View in org chart